Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-02

Clinical Trial Update: Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating fecal microbiota transplantation in combination with dietary fiber for ulcerative colitis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Ulcerative Colitis, Inflammatory Bowel Diseases | Phase 2 | Status: COMPLETED | Results posted: 2024-04-02